Glenmark, Particle Sciences to develop generic cancer drug Industry-The Economic Times — September 19, 2016 comments off The partnership will develop and market a generic version of Celgene’s ABRAXANE which is used in treatments of breast and lung cancers.
The partnership will develop and market a generic version of Celgene’s ABRAXANE which is used in treatments of breast and lung cancers.